CA2648165A1 - Biomarkers for endometrial proliferation - Google Patents
Biomarkers for endometrial proliferation Download PDFInfo
- Publication number
- CA2648165A1 CA2648165A1 CA002648165A CA2648165A CA2648165A1 CA 2648165 A1 CA2648165 A1 CA 2648165A1 CA 002648165 A CA002648165 A CA 002648165A CA 2648165 A CA2648165 A CA 2648165A CA 2648165 A1 CA2648165 A1 CA 2648165A1
- Authority
- CA
- Canada
- Prior art keywords
- gene
- alpha
- collagen
- type
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pregnancy & Childbirth (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0608483.4A GB0608483D0 (en) | 2006-04-28 | 2006-04-28 | Biomarkers for endometrial proliferation |
GB0608483.4 | 2006-04-28 | ||
PCT/EP2007/003694 WO2007128429A1 (en) | 2006-04-28 | 2007-04-26 | Biomarkers for endometrial proliferation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2648165A1 true CA2648165A1 (en) | 2007-11-15 |
Family
ID=36590031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002648165A Abandoned CA2648165A1 (en) | 2006-04-28 | 2007-04-26 | Biomarkers for endometrial proliferation |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2016417A1 (ja) |
JP (1) | JP2009535023A (ja) |
KR (1) | KR20090009212A (ja) |
CN (1) | CN101427139A (ja) |
AU (1) | AU2007247497A1 (ja) |
BR (1) | BRPI0710912A2 (ja) |
CA (1) | CA2648165A1 (ja) |
GB (1) | GB0608483D0 (ja) |
MX (1) | MX2008013789A (ja) |
WO (1) | WO2007128429A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2078728A1 (en) * | 2008-01-14 | 2009-07-15 | Université de Liège | Novel isoform of versican and use in diagnosis and therapy |
JP2024518180A (ja) * | 2021-05-17 | 2024-04-25 | エフ. ホフマン-ラ ロシュ アーゲー | 腺筋症の非侵襲的診断のための血液バイオマーカーとしてのsFRP4 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1159601A (en) * | 1999-11-03 | 2001-05-14 | Metris Therapeutics Limited | Agents implicated in endometriosis |
US20050214836A1 (en) * | 2002-08-30 | 2005-09-29 | Oncotherapy Science, Inc. | Method of diagnosing ovarian endometriosis |
WO2004056858A2 (en) * | 2002-12-23 | 2004-07-08 | Ingenium Pharmaceuticals Ag | Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
-
2006
- 2006-04-28 GB GBGB0608483.4A patent/GB0608483D0/en not_active Ceased
-
2007
- 2007-04-26 WO PCT/EP2007/003694 patent/WO2007128429A1/en active Application Filing
- 2007-04-26 BR BRPI0710912-1A patent/BRPI0710912A2/pt not_active IP Right Cessation
- 2007-04-26 CA CA002648165A patent/CA2648165A1/en not_active Abandoned
- 2007-04-26 MX MX2008013789A patent/MX2008013789A/es not_active Application Discontinuation
- 2007-04-26 AU AU2007247497A patent/AU2007247497A1/en not_active Abandoned
- 2007-04-26 JP JP2009506989A patent/JP2009535023A/ja active Pending
- 2007-04-26 CN CNA2007800144769A patent/CN101427139A/zh active Pending
- 2007-04-26 KR KR1020087026231A patent/KR20090009212A/ko not_active Application Discontinuation
- 2007-04-26 EP EP07724624A patent/EP2016417A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2007128429A1 (en) | 2007-11-15 |
JP2009535023A (ja) | 2009-10-01 |
EP2016417A1 (en) | 2009-01-21 |
AU2007247497A1 (en) | 2007-11-15 |
BRPI0710912A2 (pt) | 2012-02-22 |
CN101427139A (zh) | 2009-05-06 |
MX2008013789A (es) | 2008-11-14 |
GB0608483D0 (en) | 2006-06-07 |
KR20090009212A (ko) | 2009-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060134688A1 (en) | Genes overexpressed in prostate disorders as diagnostic and therapeutic targets | |
US20030144234A1 (en) | Methods for the treatment of chronic pain and compositions therefor | |
US20090304704A1 (en) | Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash) | |
JP2018078911A (ja) | c−MAFを用いた前立腺がん転移の診断、予後診断および処置のための方法 | |
JP2009538915A (ja) | 妊娠の合併症を診断および治療する方法 | |
Tschugguel et al. | Induction of inducible nitric oxide synthase expression in human secretory endometrium | |
AU3839400A (en) | Proliferation inhibitor for androgen-independent tumor | |
JP2005110602A (ja) | アトピー性皮膚炎の疾患マーカー及びその利用 | |
He et al. | Abnormal activation of the sonic hedgehog signaling pathway in endometriosis and its diagnostic potency | |
CN109952511B (zh) | 用于确定先兆子痫的风险的测定方法 | |
JP2010185878A (ja) | 栄養膜細胞の細胞死、分化、浸潤、および/または細胞融合および代謝回転に関連する状態の診断用組成物および治療方法 | |
US20020137064A1 (en) | Id-1 and Id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma | |
CA2648165A1 (en) | Biomarkers for endometrial proliferation | |
KR100948808B1 (ko) | 간암 마커로서의 lcn2 유전자, 단백질 및 간암 진단키트 | |
US20060188885A1 (en) | High throughput functional genomic screening methods for osteoarthritis | |
US20120177665A1 (en) | Method of diagnosing and treating interstitial cystitis | |
JP2002517209A (ja) | 子宮内膜症の診断および処置におけるプロサイモシンの使用 | |
JP4120778B2 (ja) | 骨代謝異常疾患マーカー及びその利用 | |
US20030096781A1 (en) | IL-8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma | |
KR100861464B1 (ko) | 발암/전이유전자 tip41과 이에 의해 코드되는 단백질 및이를 이용한 발암 및 전이 진단 키트 | |
US20120195916A1 (en) | Method of treating cancer by inhibiting trim59 expression or activity | |
US20060128644A1 (en) | Use of mob-5 in pain | |
KR20230010414A (ko) | Csde1을 유효성분으로 포함하는 삼중음성유방암 전이 예측용 바이오마커 조성물 | |
JP2004173553A (ja) | 心不全の疾患マーカー及びその利用 | |
Keller-Melchior et al. | Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |